Sixty percent of the RA patients presented positive values of anti-citrullinated protein antibodies (ACPA) and the median disease duration was of 17.60 years and the disease activity score 28 (DAS28) calculated at patient recruitment was of 5.74 (Table 1). The gene discussed is PRTN3; the disease is rheumatoid arthritis.